These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 398207)

  • 21. In brief: heptavalent botulism antitoxin.
    Med Lett Drugs Ther; 2014 May; 56(1443):44. PubMed ID: 24869716
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosecurity. As new botulism threat implodes, more questions.
    Enserink M
    Science; 2015 Feb; 347(6225):934-5. PubMed ID: 25722389
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
    Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
    PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):105-12. PubMed ID: 3884243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attempts to quantity Clostridium botulinum type A toxin and antitoxin in serum of two cases of infant botulism in Japan.
    Takahashi M; Noda H; Takeshita S; Fujiwara T; Nakanoin H; Mizunoya T; Sakaguchi G
    Jpn J Med Sci Biol; 1990 Dec; 43(6):233-7. PubMed ID: 2101138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An improved method for development of toxoid vaccines and antitoxins.
    Jones RG; Liu Y; Rigsby P; Sesardic D
    J Immunol Methods; 2008 Aug; 337(1):42-8. PubMed ID: 18571196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous antibody production to botulinum toxin in an adult with intestinal colonization botulism and underlying Crohn's disease.
    Griffin PM; Hatheway CL; Rosenbaum RB; Sokolow R
    J Infect Dis; 1997 Mar; 175(3):633-7. PubMed ID: 9041335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of Clostridium botulinum type C antitoxin titers in mink and guinea pigs to protection against type C intoxication in mink.
    Kolbe DR; Coe Clough NE
    Anaerobe; 2008 Apr; 14(2):128-30. PubMed ID: 18032073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations.
    Torgeman A; Ozeri E; Ben David A; Diamant E; Rosen O; Schwartz A; Barnea A; Makovitzki A; Mimran A; Zichel R
    Toxins (Basel); 2017 May; 9(6):. PubMed ID: 28555060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1991; 14(1):11-5. PubMed ID: 2013205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of Clostridium botulinum type E from soil of Gwalior, India.
    Dhaked RK; Sharma SK; Parida MM; Singh L
    J Nat Toxins; 2002 Feb; 11(1):49-56. PubMed ID: 11829060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Titration of botulinum toxins for lethal toxicity by intravenous injection into mice.
    Kondo H; Shimizu T; Kubonoya M; Izumi N; Takahashi M; Sakaguchi G
    Jpn J Med Sci Biol; 1984 Jun; 37(3):131-5. PubMed ID: 6503025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of a toxic component of Clostridium botulinum types C and D by trypsin.
    Eklund MW; Poysky FT
    Appl Microbiol; 1972 Jul; 24(1):108-13. PubMed ID: 4560464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid.
    Torii Y; Tokumaru Y; Kawaguchi S; Izumi N; Maruyama S; Mukamoto M; Kozaki S; Takahashi M
    Vaccine; 2002 Jun; 20(19-20):2556-61. PubMed ID: 12057613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of the Japanese National Standard, Equine Botulinum Antitoxin Type A, and Factors Affecting Standardization.
    Yutani M; Senoh M; Yano H; Kenri T; Iwaki M
    Jpn J Infect Dis; 2024 Jan; 77(1):16-20. PubMed ID: 37648491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.